So this is what the company works with until a long range financing can be found.
It just might make it, as they mentioned closing up some of the research projects for the time being. Finally I say. I mean what is their problem with having the company earn its own keep before going into several other directions bleeding cash for research it can ill afford?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.